Cerus (CERS) Exchange Rate Effect (2020 - 2026)
Cerus (CERS) reported Exchange Rate Effect of -$122000.0 for Q1 2026, down 165.59% on a YoY basis from $186000.0 in Q1 2025, and down 103.33% sequentially from -$60000.0 in Q3 2025.
Cerus (CERS) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Cerus (CERS) has 7 years of Exchange Rate Effect data on file, last reported at -$122000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 165.59% year-over-year to -$122000.0; the trailing twelve-month figure through Mar 2026 stood at $28000.0 (down 67.06% YoY), and the FY2025 full-year result was $336000.0, up 275.92% from the prior year.
- Exchange Rate Effect fell to -$122000.0 in Q1 2026, from -$60000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $401000.0 in Q4 2022 to a low of -$434000.0 in Q2 2022.
- A 5-year average of -$52000.0 and a median of -$75000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect plunged 1381.25% in 2024 and surged 1412.5% in 2025, its largest moves.
- Tracing CERS's Exchange Rate Effect over 5 years: stood at $401000.0 in 2022, then slumped by 103.99% to -$16000.0 in 2023, then sank by 1381.25% to -$237000.0 in 2024, then soared by 74.68% to -$60000.0 in 2025, then sank by 103.33% to -$122000.0 in 2026.
- Business Quant data shows CERS's Exchange Rate Effect at -$122000.0 in Q1 2026, -$60000.0 in Q3 2025, and $210000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 33.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -2.80 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -37.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 45.66 Mn |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | -122,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122,000.00 |
| Mar 31, 2026 | -122,000.00 |
| Sep 30, 2025 | -60,000.00 |
| Sep 30, 2025 | -60,000.00 |
| Jun 30, 2025 | 210,000.00 |
| Jun 30, 2025 | 210,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Dec 31, 2024 | -237,000.00 |
| Dec 31, 2024 | -237,000.00 |
| Sep 30, 2024 | 152,000.00 |
| Sep 30, 2024 | 152,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Mar 31, 2024 | -90,000.00 |
| Mar 31, 2024 | -90,000.00 |
| Dec 31, 2023 | -16,000.00 |
| Dec 31, 2023 | -16,000.00 |
| Sep 30, 2023 | -107,000.00 |
| Sep 30, 2023 | -107,000.00 |